World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
87
Citations
22737
World Ranking
2883
National Ranking
181

Overview

Hisashi Narimatsu is affiliated with the National Institute of Advanced Industrial Science and Technology in Japan. Their research primarily spans fields within Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on molecular and clinical studies.

The main subfields of Narimatsu's work include Molecular Biology, Epidemiology, Immunology, Hepatology, and Surgery. This multidisciplinary approach supports investigations into various topics such as Glycosylation and Glycoproteins Research, Hepatitis B Virus Studies, Hepatitis C Virus Research, Liver Disease Diagnosis and Treatment, Galectins and Cancer Biology, Immunotherapy and Immune Responses, and Renal Transplantation Outcomes and Treatments.

Recent significant papers authored or coauthored by Narimatsu include:

  • The GlyCosmos Portal: a unified and comprehensive web resource for the glycosciences (2020), published in Nature Methods
  • Comparative Glycomic Analysis of Exosome Subpopulations Derived from Pancreatic Cancer Cell Lines (2020), published in Journal of Proteome Research
  • ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface (2022), published in Oncogene
  • Cataloging natural sialic acids and other nonulosonic acids (NulOs), and their representation using the Symbol Nomenclature for Glycans (2023), published in Glycobiology
  • N-glycan structures of Wisteria floribunda agglutinin-positive Mac2 binding protein in the serum of patients with liver fibrosis (2021), published in Glycobiology

Frequent collaborators in Narimatsu's research include Kiyohiko Angata, Hiroyuki Kaji, Atsushi Kuno, Takashi Sato, and M. Sogabe. These collaborations contribute to the breadth and depth of their investigations, particularly in complex biochemical and clinical research contexts.

Narimatsu's publications often appear in specialized venues such as Glycobiology, Biochimica et Biophysica Acta (BBA) - General Subjects, Clinical and Experimental Nephrology, Nature Methods, and the Journal of Proteome Research. These journals reflect the scientist's focus on glycobiology, proteomics, and clinical biochemistry.

Best Publications

  • Symbol Nomenclature for Graphical Representations of Glycans.

    Ajit Varki;Richard D. Cummings;Markus Aebi;Nicole H. Packer

  • Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells.

    Katsue Suzuki-Inoue;Yukinari Kato;Osamu Inoue;Mika Kato Kaneko

  • Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study.

    Yoshinao Wada;Parastoo Azadi;Catherine E. Costello;Anne Dell

  • Updates to the Symbol Nomenclature for Glycans guidelines.

    Sriram Neelamegham;Kiyoko Aoki-Kinoshita;Evan Bolton;Martin Frank

  • A serum "sweet-doughnut" protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis.

    Atsushi Kuno;Yuzuru Ikehara;Yasuhito Tanaka;Kiyoaki Ito

  • Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2

    Yukinari Kato;Mika Kato Kaneko;Akiko Kunita;Hiromi Ito

  • Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

    Kazumi Yamasaki;Masakuni Tateyama;Seigo Abiru;Atsumasa Komori

  • Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain

    Yukinari Kato;Mika Kato Kaneko;Atsushi Kuno;Noboru Uchiyama

  • Cloning and sequencing of cDNA of bovine N-acetylglucosamine (beta 1-4)galactosyltransferase.

    Hisashi Narimatsu;Sudhir Sinha;Keith Brew;Hiroto Okayama

  • Molecular cloning and characterization of a novel UDP-GlcNAc : GalNAc-peptide β1,3-N-acetylglucosaminyltransferase (β3Gn-T6), an enzyme synthesizing the core 3 structure of O-glycans

    Toshie Iwai;Niro Inaba;Andreas Naundorf;Andreas Naundorf;Yan Zhang

  • Cloning, Expression, and Characterization of a Novel UDP-galactose:β-N-Acetylglucosamine β1,3-Galactosyltransferase (β3Gal-T5) Responsible for Synthesis of Type 1 Chain in Colorectal and Pancreatic Epithelia and Tumor Cells Derived Therefrom

    Soichiro Isshiki;Akira Togayachi;Takashi Kudo;Shoko Nishihara

  • Lewis and Secretor Gene Dosages Affect CA19-9 and DU-PAN-2 Serum Levels in Normal Individuals and Colorectal Cancer Patients

    Hisashi Narimatsu;Hiroko Iwasaki;Fumiaki Nakayama;Yuzuru Ikehara

  • A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.

    Hisashi Narimatsu;Hiromichi Sawaki;Atsushi Kuno;Hiroyuki Kaji

  • A novel strategy for mammalian cell surface glycome profiling using lectin microarray

    Hiroaki Tateno;Noboru Uchiyama;Atsushi Kuno;Akira Togayachi

  • Molecular Genetic Analysis of the Human Lewis Histo-blood Group System*

    S Nishihara;H Narimatsu;H Iwasaki;S Yazawa

  • A focused microarray approach to functional glycomics: transcriptional regulation of the glycome

    Elena M. Comelli;Steven R. Head;Tim Gilmartin;Thomas Whisenant

  • Noroviruses Distinguish between Type 1 and Type 2 Histo-Blood Group Antigens for Binding

    Haruko Shirato;Satoko Ogawa;Hiromi Ito;Takashi Sato

  • Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

    Ken Shirabe;Yuki Bekki;Dolgormaa Gantumur;Kenichiro Araki

  • A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

    Takeo Toshima;Ken Shirabe;Toru Ikegami;Tomoharu Yoshizumi

  • Cloning and Characterization of a New Human UDP-N-Acetyl-α-d-galactosamine:PolypeptideN-Acetylgalactosaminyltransferase, Designated pp-GalNAc-T13, That Is Specifically Expressed in Neurons and Synthesizes GalNAc α-Serine/Threonine Antigen *

    Yan Zhang;Hiroko Iwasaki;Hiroko Iwasaki;Han Wang;Takashi Kudo

Frequent Co-Authors

Atsushi Kuno
Atsushi Kuno National Institute of Advanced Industrial Science and Technology
Takashi Kudo
Takashi Kudo University of Tsukuba
Yuzuru Ikehara
Yuzuru Ikehara Chiba University
Hiroko Iwasaki
Hiroko Iwasaki Keio University
Jun Hirabayashi
Jun Hirabayashi Nagoya University
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Kiyoko F. Aoki-Kinoshita
Kiyoko F. Aoki-Kinoshita Soka University of America
Koji Kimata
Koji Kimata Aichi Medical University
Yasuhito Tanaka
Yasuhito Tanaka Kumamoto University
Naoyuki Taniguchi
Naoyuki Taniguchi Osaka University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Hisashi Narimatsu

Trending Scientists

Recently Published Articles